LOGIN
AAHS 2015: Exparel vs. Marcaine for postoperative analgesia in outpatient wrist procedures
February 2015
AAHS 2015: Exparel vs. Marcaine for postoperative analgesia in outpatient wrist procedures
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Bupivicaine Extended-Release Liposome vs. Marcaine for Early Post-Operative Pain Control Following Wrist Operations: A Prospective Randomized Double-Blind Controlled Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
28 patients were randomized to recieve either Exparel (bupivacaine extended-release liposome) or Marcaine (bupivacaine) following either carpometacarpal arthroplasty (CMCA) or proximal row carpectomy (PRC). The purpose of the study was to determine whether Exparel was effective in reducing pain, reducing opioid use and opioid side effects, and improving long-term hand function when compared to Mar...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.